Working… Menu

Tolerability and Efficacy of Midostaurin to 10-day Decitabine in Unfit Adult AML and High Risk MDS Patients (HO155)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT04097470
Recruitment Status : Recruiting
First Posted : September 20, 2019
Last Update Posted : January 10, 2020
Swiss Group for Clinical Cancer Research
Information provided by (Responsible Party):
Stichting Hemato-Oncologie voor Volwassenen Nederland

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : October 2021
Estimated Study Completion Date : March 2026